title: Uncertainty about mapping future actions into rewards may underlie performance on multiple measures of impulsivity in behavioral addiction: evidence from Parkinson's disease.
abstract: A subset of patients with Parkinson's disease (PD) develops behavioral addictions, which may be due to their dopamine replacement therapy. Recently, several groups have been comparing PD patients with and without behavioral addictions on tasks that are thought to measure aspects of impulsivity. Several of these experiments, including information sampling, a bias toward novel stimuli and temporal discounting, have shown differences between PD patients with and without behavioral addictions. We have developed a unifying theoretical framework that allows us to model behavior in all three of these tasks. By exploring the performance of the patient groups on the three tasks with a single framework, we can ask questions about common mechanisms that underlie all three. Our results suggest that the effects seen in all three tasks can be accounted for by uncertainty about the ability to map future actions into rewards. More specifically, the modeling is consistent with the hypothesis that the group with behavioral addictions behaves as if they cannot use information provided within the experimental context to improve future reward guided actions. Future studies will be necessary to more firmly establish (or refute) this hypothesis. We discuss this result in light of what is known about the pathology that underlies the behavioral addictions in the PD patients.
authors.affiliation: Laboratory of Neuropsychology, NIMH/NIH, Building 49 Room 1B80, 49 Convent Drive MSC 4415, Bethesda, MD 20892-4415, USA. bruno.averbeck@nih.gov
authors.forename: Bruno B
authors.initials: BB
authors.lastname: Averbeck
authors.forename: Atbin
authors.initials: A
authors.lastname: Djamshidian
authors.forename: Sean S
authors.initials: SS
authors.lastname: O'Sullivan
authors.forename: Charlotte R
authors.initials: CR
authors.lastname: Housden
authors.forename: Jonathan P
authors.initials: JP
authors.lastname: Roiser
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Lees
mesh_terms: D000328:Adult; D000368:Aged; D016739:Behavior, Addictive / Q000523:psychology*; D005260:Female; D006801:Humans; D007175:Impulsive Behavior / Q000523:psychology*; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000523:psychology*; D012201:Reward; D035501:Uncertainty
references.citation: PLoS One. 2012;7(3):e32889
references.pmid: 22427905
references.citation: Neuropsychopharmacology. 2010 Oct;35(11):2155-64
references.pmid: 20631686
references.citation: Mov Disord. 2012 Aug;27(9):1137-45
references.pmid: 22821557
references.citation: Neuron. 2011 Feb 24;69(4):680-94
references.pmid: 21338879
references.citation: Exp Clin Psychopharmacol. 2008 Apr;16(2):124-31
references.pmid: 18489016
references.citation: Schizophr Res. 2011 Apr;127(1-3):115-22
references.pmid: 20810252
references.citation: Trends Cogn Sci. 2012 Jan;16(1):81-91
references.pmid: 22155014
references.citation: Med J Aust. 2009 Jan 19;190(2):97
references.pmid: 19236300
references.citation: Neurosci Biobehav Rev. 2008;32(4):777-810
references.pmid: 18295884
references.citation: Clin Psychol Rev. 2006 Aug;26(4):379-95
references.pmid: 16504359
references.citation: Arch Neurol. 2010 May;67(5):589-95
references.pmid: 20457959
references.citation: Science. 2004 Oct 15;306(5695):503-7
references.pmid: 15486304
references.citation: J Neurophysiol. 2010 May;103(5):2513-31
references.pmid: 20181737
references.citation: Trends Cogn Sci. 2001 Jan 1;5(1):10-16
references.pmid: 11164731
references.citation: J Neurosci. 2010 Jun 30;30(26):8888-96
references.pmid: 20592211
references.citation: Age Ageing. 2011 Sep;40(5):614-21
references.pmid: 21788252
references.citation: Cogn Neuropsychiatry. 2011 Sep;16(5):422-47
references.pmid: 21480015
references.citation: J Exp Psychol Gen. 1999 Mar;128(1):78-87
references.pmid: 10100392
references.citation: J Neurosci. 2011 Nov 30;31(48):17572-82
references.pmid: 22131418
references.citation: Ann Neurol. 2011 Jun;69(6):986-96
references.pmid: 21416496
references.citation: J Cogn Neurosci. 2012 Aug;24(8):1709-24
references.pmid: 22571461
references.citation: Br J Soc Clin Psychol. 1977 Feb;16(1):57-68
references.pmid: 843784
references.citation: Biol Psychiatry. 2006 Sep 1;60(5):515-22
references.pmid: 16448627
references.citation: Nature. 2006 Jun 15;441(7095):876-9
references.pmid: 16778890
references.citation: Neuron. 2008 Jun 26;58(6):967-73
references.pmid: 18579085
references.citation: Clin Neuropharmacol. 2011 Mar-Apr;34(2):66-70
references.pmid: 21412200
references.citation: J Abnorm Psychol. 1966 Feb;71(1):17-24
references.pmid: 5902550
references.citation: Neurobiol Dis. 2010 Jul;39(1):98-104
references.pmid: 20338240
references.citation: Parkinsonism Relat Disord. 2011 May;17(4):260-4
references.pmid: 21310646
references.citation: J Pharmacol Exp Ther. 2002 Nov;303(2):805-14
references.pmid: 12388667
references.citation: Neuropsychologia. 2011 Jul;49(9):2483-8
references.pmid: 21565210
references.citation: Psychol Rep. 1965 Apr;16:547-54
references.pmid: 14285869
references.citation: Parkinsonism Relat Disord. 2011 Mar;17(3):212-4
references.pmid: 21247790
references.citation: Brain. 2012 Jun;135(Pt 6):1871-83
references.pmid: 22508958
references.citation: Nat Neurosci. 2010 May;13(5):538-9
references.pmid: 20348919
references.citation: Neuron. 2008 Dec 26;60(6):1142-52
references.pmid: 19109917
references.citation: Nat Neurosci. 2007 Dec;10(12):1625-33
references.pmid: 17982449
references.citation: J Neurosci. 2012 Mar 14;32(11):3612-28
references.pmid: 22423085
references.citation: J Neurosci. 2009 Jul 29;29(30):9575-81
references.pmid: 19641120
references.citation: J Neurol Sci. 2011 Nov 15;310(1-2):197-201
references.pmid: 21683375
references.citation: Brain. 2011 Apr;134(Pt 4):969-78
references.pmid: 21349901
references.citation: Mov Disord. 2007 Sep 15;22(12):1757-63
references.pmid: 17580327
references.citation: J Nerv Ment Dis. 1993 May;181(5):309-12
references.pmid: 8501447
references.citation: Behav Pharmacol. 2009 Sep;20(5-6):390-9
references.pmid: 19724194
references.citation: Neural Netw. 2006 Oct;19(8):981-1012
references.pmid: 16952441
references.citation: Neuron. 2010 Jan 14;65(1):135-42
references.pmid: 20152119
references.citation: Mov Disord. 2010 Oct 15;25(13):2203-10
references.pmid: 20721918
references.citation: J Gambl Stud. 2009 Sep;25(3):425-31
references.pmid: 19241148
references.citation: Brain. 2011 May;134(Pt 5):1438-46
references.pmid: 21596771
references.citation: Ann Neurol. 2006 May;59(5):852-8
references.pmid: 16557571
references.citation: Psychopharmacology (Berl). 2010 Jan;207(4):645-59
references.pmid: 19838863
references.citation: Annu Rev Psychol. 2004;55:493-518
references.pmid: 14744224
references.citation: Science. 2004 Dec 10;306(5703):1940-3
references.pmid: 15528409
references.citation: Brain. 2009 May;132(Pt 5):1376-85
references.pmid: 19346328
references.citation: J Mot Behav. 1981 Dec;13(4):286-300
references.pmid: 15215075
references.citation: Mov Disord. 2011 Feb 1;26(2):225-33
references.pmid: 21284039
references.citation: Mov Disord. 2010 Aug 15;25(11):1660-9
references.pmid: 20589879